大麻和精神病：我们知道什么，我们应该做什么？
Cannabis and psychosis: what do we know and what should we do?
机构信息
National Institute for Health Research (NIHR) Biomedical Research Centre (BRC),South London and Maudsley NHS Foundation Trust,UK;Department of Psychosis Studies,Institute of Psychiatry, Psychology and Neuroscience,King's College London,UK.
National Institute for Health Research (NIHR) Biomedical Research Centre (BRC),South London and Maudsley NHS Foundation Trust;Department of Psychosis Studies,Institute of Psychiatry, Psychology and Neuroscience,King's College London,UK;Department of Psychiatry,Experimental Biomedicine and Clinical Neuroscience (BIONEC),University of Palermo,Italy.
出版信息
Br J Psychiatry. 2018 Apr;212(4):195-196. doi: 10.1192/bjp.2018.1.
It is now incontrovertible that heavy use of cannabis increases the risk of psychosis. There is a dose-response relationship and high potency preparations and synthetic cannabinoids carry the greatest risk. It would be wise to await the outcome of the different models of legalisation that are being introduced in North America, before deciding whether or not to follow suit. Declaration of interest None.
现在已经无可争议的是，大量使用大麻会增加患精神病的风险。存在剂量反应关系，高浓度制剂和合成大麻素带来的风险最大。在决定是否效仿之前，明智的做法是等待北美的不同合法化模式的结果。
利益声明
无。
Zotero 插件